Skip to main content

DF 7.5 (Darifenacin Hydrobromide Extended Release 7.5 mg)

Pill with imprint DF 7.5 is White, Round and has been identified as Darifenacin Hydrobromide Extended Release 7.5 mg. It is supplied by Actavis Pharma, Inc.

Darifenacin is used in the treatment of overactive bladder; urinary frequency; urinary incontinence and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Darifenacin 7.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for DF 7.5

Darifenacin Hydrobromide Extended Release

DF 7.5
7.5 mg
8.00 mm
Prescription only
Drug Class
Urinary antispasmodics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Actavis Pharma, Inc.
Inactive Ingredients
calcium phosphate dibasic anhydrous, hypromelloses, magnesium stearate, polyethylene glycol (PEG) 200, magnesium silicate, titanium dioxide

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00591-4375 (Discontinued) Watson Pharmaceuticals, Inc.
00430-0170 Warner Chilcott
35356-0273 Lake Erie Medical and Surgical Supply (repackager)

Get help with Imprint Code FAQs.

Related Images for "DF 7.5"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.